Pedicting sarcoid phenotypes

R. M. Du Bois (London, United Kingdom)

Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Number: 7
Disease area: Interstitial lung diseases

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. M. Du Bois (London, United Kingdom). Pedicting sarcoid phenotypes. Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The granulomas morphology and clinical picture of sarcoidosis.
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017

Pneumonia-like sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 233s
Year: 2003

The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Phenotypes of organ involvement in sarcoidosis
Source: Eur Respir J, 51 (1) 1700991; 10.1183/13993003.00991-2017
Year: 2018



Immunophenotype of granuloma cells in sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 374s
Year: 2005

Phenotyping of the inflammatory sarcoid response
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002

Extrensic allergic alveolitis in differential diagnosis of diffuse micronodular appearance
Source: Eur Respir J 2006; 28: Suppl. 50, 96s
Year: 2006

Neoplastic markers in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Variants of atypical course of sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005

Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis?
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Differential expression of ubiquitin and PU.1 in granulomatous lesions of tuberculosis and sarcoidosis
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

mTORC1 signaling in granulomatous lesions is not specific for sarcoidosis
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



Necrotising sarcoid granulomatosis as a rare diferential diagnosis of pulmonary nodules
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

Clinical and radiological variants of fibrosis pulmonary sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Clinical phenotypes of extra-pulmonary sarcoidosis. The EpiSarc study
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018